Addex Therapeutics - 53 Year Dividend History | ADXN
Historical dividend payout and yield for Addex Therapeutics (ADXN) since 1971. The current TTM dividend payout for Addex Therapeutics (ADXN) as of November 20, 2024 is $0.00. The current dividend yield for Addex Therapeutics as of November 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Drug Manufacturing |
$0.008B |
$0.002B |
|
Addex Therapeutics Ltd is a clinical-stage pharmaceutical company. It is focused on the development and commercialization of small molecule drugs for neurological disorders. The company's lead drug candidate includes dipraglurant, ADX71149 which are in clinical stage. Its Preclinical programs include GABAB PAM for CMT1A, mGlu7 NAM for PTSD, mGlu2 NAM for mild neurocognitive disorders, mGlu4 PAM for Parkinson's disease and mGlu3 PAM for neurodegenerative disorders. GABAB PAM program has been licensed to Indivior PLC for the treatment of addiction. Addex Therapeutics Ltd is based in Geneva, Switzerland.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
